HBK Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HBK Investments's BMY Position: Q3 2023 in Review
HBK Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 9,760 shares — an estimated $624K sold.
HBK Investments first reported a position in BMY in Q2 2014 and held it in 16 quarters. The position peaked at $38.4M in Q2 2018. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- HBK Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- HBK Investments sold 9,760 Bristol-Myers Squibb shares in Q3 2023, an estimated $624K.
- HBK Investments first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 16 quarters.
- HBK Investments's Bristol-Myers Squibb position peaked at $38.4M in Q2 2018.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.